Cystic Fibrosis News Today Weekly Digest

Cystic Fibrosis Weekly Update Contents: Aridis to Start Phase 1/2a Trial for Inhalable Antibacterial Therapy AR-501 in CF Patients Inhaled Hypertonic Saline Improves Lung Health in Preschoolers with CF, Study Shows Aridis to Start Phase 1/2a Trial for Inhalable Antibacterial Therapy AR-501 in CF Patients Dec 07, 2018 07:00 am | Alice Melão Aridis Pharmaceuticals is planning to launch a Phase 1/2a clinical trial in the beginning of 2019 to evaluate the potential of its investigational antibacterial compound AR-501 (gallium citrate) in patients with cystic fibrosis (CF). This follows the approval of the Investigational New Drug application for AR-501 by the U.S. Food and Drug Administration (FDA). The […] The post Aridis to Start Phase 1/2a Trial for Inhalable Antibacterial Therapy AR-501 in CF Patients appeared first on Cystic Fibrosis News Today. Read More Inhaled Hypertonic Saline Improves Lung Health in Preschoolers with CF, Study Shows Dec 06, 2018 07:00 am | Jose Marques Lopes, PhD Preschoolers with cystic fibrosis (CF) treated with inhaled hypertonic saline in a clinical trial showed significant improvement in lung function, PARI, the company whose solution and equipment was used in the study, reports. The Saline Hypertonic in Preschoolers (SHIP) study (NCT02378467) examined the effectiveness of treatment with 7% hypertonic saline against 0.9% isotonic saline, given by jet nebulizer twice daily […] The post Inhaled Hypertonic Saline Improves Lung Health in Preschoolers with CF, Study Showsappeared first on Cystic Fibrosis News Today. Read More   Recent News CF Patients Benefit from Virtual Learning, New Educational Programs The Toon Trauma Triggers Mastercard Executives Lead the Way in Growing Relationship with CF Foundation For the First Time, I’m Feeling Thankless This Holiday Season Researchers Working on Vaccine Against P. aeruginosa Before Infection Sets In